Supreme Court ruling throws Trump administration’s tariff strategy into flux. What it means for global trade, U.S. economy

Supreme Court ruling throws Trump administration’s tariff strategy into flux. What it means for global trade, U.S. economy


Key Points
  • U.S. President Donald Trump’s decision to reimplement tariffs after the Supreme Court struck some down only served to aggravate global trade tensions.
  • As uncertainties rise, foreign governments and big businesses are likely to adopt more cautious stances on investments as well as imports and exports, particularly on deals that involve the U.S. — an outcome that’s likely to hurt the U.S. economy.
  • Amid Trump’s tariff threats, some countries are diverting their trade to China, which saw a spike in its exports and imports at the end of last year, according to Chinese customs data.



Source

Stocks making the biggest moves midday: KKR, Blackstone, CrowdStrike, International Paper & more
Finance

Stocks making the biggest moves midday: KKR, Blackstone, CrowdStrike, International Paper & more

Check out the companies making the biggest moves midday: Financials — The financials sector of the S & P 500 slid more than 3% in midday trading, the worst performer in the broad market. Alternative asset managers KKR and Blackstone slid roughly 9% and 7%, respectively, after activist hedge fund Saba Capital Management and Cox […]

Read More
Bitcoin falls to nearly ,000 as 2026 crypto woes continue
Finance

Bitcoin falls to nearly $64,000 as 2026 crypto woes continue

Key Points Bitcoin traded as low as $64,830 early Monday. The token slid nearly 5% from Sunday to Monday, hitting at one point its lowest level in more than two weeks. Investors are rotating out of risk-on trades like bitcoin and turning to gold as confusion over Trump’s latest tariffs has spread and a war […]

Read More
Stocks making the biggest moves premarket: Arcellx, Novo Nordisk, Domino’s Pizza and more
Finance

Stocks making the biggest moves premarket: Arcellx, Novo Nordisk, Domino’s Pizza and more

Check out the companies making headlines before the bell. Arcellx — The biotech stock surged 78% after Gilead Sciences said Monday it agreed to acquire Arcellx for $7.8 billion, offering $115 per share in cash at closing and one contingent value right of $5 per share. Arcellx focuses on immunotherapies for patients with cancer and […]

Read More